Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Pons

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Hepato-Gastroenterology|July 9, 2003
Treatment of esophagojejunostomic leakage by cervical stapling and loop jejunostomyOlivier Turrini, Julien Pons, Jean Hardwigsen, et al.
Journal of Medicinal Chemistry|March 3, 2010
Fragment-based deconstruction of Bcl-xL inhibitorsSarah Barelier, Julien Pons, Olivier Marcillat, et al.
Journal of Medicinal Chemistry|June 26, 2010
Ligand specificity in fragment-based drug designSarah Barelier, Julien Pons, Kalle Gehring, et al.
Peptides|November 13, 2007
Phosphorylation-dependent structure of ATF4 peptides derived from a human ATF4 protein, a member of the family of transcription factorsJulien Pons, Nathalie Evrard-Todeschi, Gildas Bertho, et al.
Journal of Chemical Information and Modeling|December 5, 2008
Structure of the complex between phosphorylated substrates and the SCF beta-TrCP ubiquitin ligase receptor: a combined NMR, molecular modeling, and docking approachNathalie Evrard-Todeschi, Julien Pons, Josyane Gharbi-Benarous, et al.
Plos One|March 23, 2010
Discovery of fragment molecules that bind the human peroxiredoxin 5 active siteSarah Barelier, Dominique Linard, Julien Pons, et al.
Biochemistry|February 27, 2007
Structural studies on 24P-IkappaBalpha peptide derived from a human IkappaB-alpha protein related to the inhibition of the activity of the transcription factor NF-kappaBJulien Pons, Nathalie Evrard-Todeschi, Gildas Bertho, et al.
Biochemistry|December 7, 2007
Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-cateninJulien Pons, Nathalie Evrard-Todeschi, Gildas Bertho, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Hepato-Gastroenterology|July 9, 2003
Treatment of esophagojejunostomic leakage by cervical stapling and loop jejunostomyOlivier Turrini, Julien Pons, Jean Hardwigsen, et al.
Journal of Medicinal Chemistry|March 3, 2010
Fragment-based deconstruction of Bcl-xL inhibitorsSarah Barelier, Julien Pons, Olivier Marcillat, et al.
Journal of Medicinal Chemistry|June 26, 2010
Ligand specificity in fragment-based drug designSarah Barelier, Julien Pons, Kalle Gehring, et al.
Peptides|November 13, 2007
Phosphorylation-dependent structure of ATF4 peptides derived from a human ATF4 protein, a member of the family of transcription factorsJulien Pons, Nathalie Evrard-Todeschi, Gildas Bertho, et al.
Journal of Chemical Information and Modeling|December 5, 2008
Structure of the complex between phosphorylated substrates and the SCF beta-TrCP ubiquitin ligase receptor: a combined NMR, molecular modeling, and docking approachNathalie Evrard-Todeschi, Julien Pons, Josyane Gharbi-Benarous, et al.
Plos One|March 23, 2010
Discovery of fragment molecules that bind the human peroxiredoxin 5 active siteSarah Barelier, Dominique Linard, Julien Pons, et al.
Biochemistry|February 27, 2007
Structural studies on 24P-IkappaBalpha peptide derived from a human IkappaB-alpha protein related to the inhibition of the activity of the transcription factor NF-kappaBJulien Pons, Nathalie Evrard-Todeschi, Gildas Bertho, et al.
Biochemistry|December 7, 2007
Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-cateninJulien Pons, Nathalie Evrard-Todeschi, Gildas Bertho, et al.
Pageof 1